Enlicitide Decanoate
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for Enlicitide Decanoate, covering 2024-10-26 to 2026-08-06. Get the full timeline:
Most recent: Clinical Trial Results: A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids [Phase 3]